Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

282
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
282
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Promoting Sustainable Prescribing-A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees.

Pharmacology research & perspectives·2026
Same author

Authors response to the comments by Muhammad Salman, Muhammad Hammad Chola and Muhammad Hasan on our paper "prescribing patterns of glucagon like peptide-1 receptor agonists in the Swedish capital region: a register-based cross-sectional study".

European journal of clinical pharmacology·2026
Same author

A Cross-Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real-World Evidence.

Pharmacoepidemiology and drug safety·2026
Same author

Self-Reported Depression, Anxiety, Stress, Health-Related Quality of Life, and Diabetes Distress During a 2-Year Pedometer-Based Physical Activity Intervention in Prediabetes and Type 2 Diabetes: Secondary Outcomes of a Randomized Controlled Trial.

Journal of primary care & community health·2026
Same author

Agentic RAG for Maritime AIoT: Natural Language Access to Structured Data.

Sensors (Basel, Switzerland)·2026
Same author

Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post-COVID-19 in Sweden-An Interrupted Time Series Study.

Basic & clinical pharmacology & toxicology·2026

Related Experiment Video

Updated: Jan 11, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.3K

Drug-Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System

Ola Nordqvist1,2, Olof Björneld1,3,4, Patrick Bergman1,3

  • 1Department of Medicine and Optometry, eHealth Institute, Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden.

Clinical Pharmacology and Therapeutics
|November 10, 2025
PubMed
Summary

Clinical Decision Support Systems (CDSSs) can flag drug risks. A Swedish CDSS validation showed associations between QT-prolonging drug risk levels and adverse events like ventricular arrhythmia, though multifactorial algorithms are needed.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Related Experiment Videos

Last Updated: Jan 11, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.3K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Area of Science:

  • Pharmacovigilance
  • Clinical Informatics
  • Cardiology

Background:

  • Clinical Decision Support Systems (CDSSs) aid in identifying potential adverse drug events.
  • Drug-induced QT prolongation poses a significant cardiovascular risk.

Purpose of the Study:

  • To validate the Janusmed Risk Profile, a Swedish CDSS, by assessing its risk classifications for QT-prolonging drugs.
  • To investigate the association between CDSS-calculated risk levels and registered clinical outcomes.

Main Methods:

  • Retrospective cohort study using Swedish electronic health records (2011-2020).
  • Inclusion of 188,453 subjects exposed to QT-prolonging drugs (risk levels I-III) and matched controls (risk level 0).
  • Logistic regression analysis adjusted for covariates to evaluate outcomes including ventricular arrhythmia, Torsade de Pointes, cardiac arrest, and death.

Main Results:

  • Higher proportions of ventricular arrhythmia were observed in subjects with higher CDSS risk classifications (Level I: 0.26%, II: 0.34%, III: 0.71%) compared to controls (0.17%).
  • After adjustment for confounding factors, risk level III remained significantly associated with adverse outcomes (OR 2.1, 95% CI 1.6-2.9).
  • Other clinical outcomes showed similar trends, indicating a correlation between CDSS risk and adverse events.

Conclusions:

  • While the CDSS demonstrated an association between QT-prolonging drug risk classifications and clinical outcomes, the absolute number of affected individuals was small.
  • Concomitant factors, particularly previous diagnoses, significantly influence patient risk, highlighting the need for more comprehensive risk assessment.
  • Development of multifactorial CDSS algorithms is essential for accurately identifying high-risk patients and guiding clinical practice effectively.